Remdseivir the possible drug of COVID 19 / going out of stock

Read Time2 Minute, 6 Second
Remdseivir the possible drug of COVID 19 / going out of stock

In May US FDA issued EUA of remdesivir,

and they stated that this drug will allow in emergency cases and in the critical situation of the corona. This drug is now using for many confirmed positive coronavirus patients.

Remdesivir was previously studied in ebolavirus infection but this drug didn’t give the desire results. But, now lab technician after experimentation said;

In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68{7d6bb1f761e691f027164c9fe6d1ebbc4659a250013ce39dc45a15ede39dbac5}). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.)

Remdesivir is the possible drug:

Remdesivir is the possible drug of the coronavirus that goes out of stock for three months because of global supply.

The number of coronavirus cases increases day by day, the United States government secured almost all the stock of remdesivir.

Also Read : Dexamethasone drug proved to be effective against Corona.

Remdseivir is a drug showing positive results against corona and treated coronavirus patients are recovering with it, and show positive results on coronavirus patients.

Also Read: FDA orders Zantac drug to be recalled immediately

Rmdesivir, the first drug approved by licensing authorities in the whole United States to treat COVID 19

patients and shows other the clear results of better results from the patients.  Manufacturer of remdesivir has signed a deal with human services for half-million treatment courses of the drug.

Also Read: China Invents Coronavirus Vaccine And Decides to Launch in Pakistan

President Donald Trump is in line with has the first approach in it. India has two companies that have an emergency marketing approval from the drug controller of India.

department of health and human services said:

The department of health and human services said in us it has secured half- million courses of treatment for American hospitals.

Us department of health and services announced in July that the entire stock is effective for COVID 19 positive patients, till September anybody can buy it, but this would be sending to all over the united states for the next three months.

Remdesivir becomes high demanded drug for the treatment of COVID 19 positive patients.

Also Read: Coronavirus Vaccine: US tests first experimental vaccine

This statement clarifies that no stock will be available for the next few months for the entire world. US bought all the stock of remdesivir for the next three months.

Recent News:

About Post Author

Helen Dunmore

Hey, I'm Helen Dunmore an article writer from London Ontario, Canada. I had done a master's in mass communication and M.Phill in political science and attended many College Journalism Broadcast programs where I wrote and won. I previously had attended Humber College for media studies which included writing for television and news. I have written several publications for many news related websites. Have experience more than 7 years, yeah quite a lot for you. I love writing, an expert in article writing. Currently doing article writing for many blog posts and work as an author for many web sites. Reading is my hobby, love books more than anything in my life.

4 thoughts on “Remdseivir the possible drug of COVID 19 / going out of stock

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

India banned 59 Chinese applications including TikTok

59 Chinese Apps Banned in India: India banned the 59 Chinese applications, including the trendiest TikTok and WeChat platforms. Which shocked and saddened millions of its users. Delhi Government point of view: The Delhi government said that these applications “detrimental to India’s dominion and honor, India’s defense, national security, and … Read more